메뉴 건너뛰기




Volumn 132, Issue 1, 2014, Pages 111-114

Marked recovery of vision in children with optic pathway gliomas treated with bevacizumab

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CARBOPLATIN; CORTICOSTEROID; ERLOTINIB; IRINOTECAN; RAPAMYCIN; TEMOZOLOMIDE; VINBLASTINE; VINCRISTINE;

EID: 84892733049     PISSN: 21686165     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaophthalmol.2013.5819     Document Type: Article
Times cited : (98)

References (5)
  • 1
    • 84862162847 scopus 로고    scopus 로고
    • Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: A multicenter retrospective analysis
    • Fisher MJ, Loguidice M, Gutmann DH, et al. Visual outcomes in children with neurofibromatosis type 1-associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol. 2012;14(6):790-797.
    • (2012) Neuro Oncol. , vol.14 , Issue.6 , pp. 790-797
    • Fisher, M.J.1    Loguidice, M.2    Gutmann, D.H.3
  • 2
    • 77958574091 scopus 로고    scopus 로고
    • Optic pathway glioma: Long-term visual outcome in children without neurofibromatosis type-1
    • Campagna M, Opocher E, Viscardi E, et al. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1. Pediatr Blood Cancer. 2010;55(6):1083-1088.
    • (2010) Pediatr Blood Cancer. , vol.55 , Issue.6 , pp. 1083-1088
    • Campagna, M.1    Opocher, E.2    Viscardi, E.3
  • 3
    • 84874957098 scopus 로고    scopus 로고
    • Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas
    • Hwang EI, Jakacki RI, Fisher MJ, et al. Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas. Pediatr Blood Cancer. 2013;60(5):776-782.
    • (2013) Pediatr Blood Cancer. , vol.60 , Issue.5 , pp. 776-782
    • Hwang, E.I.1    Jakacki, R.I.2    Fisher, M.J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.